Aaron Cowley is the founder of Arranta Bio. Backed by Ampersand Capital Partners, Thermo Fisher Scientific.
Aaron Cowley is the Chief Scientific Officer at Arranta Bio, a CDMO focused on microbiome-based therapies. Previously, he co-founded Captozyme, a company that served the microbiome CDMO market for 10 years before merging with Arranta Bio in November 2019. Captozyme's enzyme therapeutic assets were spun out as Oxidien Pharmaceuticals, LLC. Cowley holds a Ph.D. in inorganic chemistry and an MBA.
Full founder directory · Investor directory · Company funding database · Fundraising library